Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma

Cancer Research

Volumn 68, Issue 20, 2008, Pages 8240-8248

  Garg, Manoj ^a   Kanojia, Deepika ^a   Khosla, Aashima ^a   Dudha, Namrata ^a   Sati, Satish ^a   Chaurasiya, Dipak ^a   Jagadish, Nirmala ^a   Seth, Amlesh ^b   Kumar, Rajive ^c   Gupta, Samir ^d   Gupta, Anju ^e   Lohiya, Nirmal Kumar ^f   Suri, Anil ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c INSTITUTE ROTARY CANCER HOSPITAL   (India)

^d ARMY HOSPITAL   (India)

^e Moolchand Hospital   (India)

^f UNIVERSITY OF RAJASTHAN   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID VECTOR; SMALL INTERFERING RNA; SPERM ANTIGEN; SPERM ASSOCIATED ANTIGEN 9; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER PATIENT; CARCINOMA CELL; CELL GROWTH; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KNOCKOUT GENE; MALE; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; TUMOR GROWTH; TUMOR XENOGRAFT; WOUND HEALING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; ANIMALS; ANTIBODIES; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMANS; IN SITU HYBRIDIZATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KIDNEY NEOPLASMS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RNA, MESSENGER; RNA, SMALL INTERFERING; SPERMATOZOA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 54249144031     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-1708     Document Type: Article

References (37)

1. Vogelzang NJ, Stadler WM. Kidney cancer. Lancet 1998;352:1691-6.
2. Motzer RJ, Russo P. Systemic therapy for renal cell carcinoma. J Urol 2000;163:408-17.
3. Togashi A, Katagiri T, Ashida S, et al. Hypoxia-inducible protein 2 (HIG2) , a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy. Cancer Res 2005;11:4817-26.
4. Suri A. Cancer testis antigens-their importance in immunotherapy and in the early detection of cancer. Expert Opin Biol Ther 2006;6:379-89.
5. Scanlan MJ, Andrew JG, Simpson GJA, Old LJ. The cancer/testis genes: Review, standardization, and commentary. Cancer Immun 2004;4:1.
6. Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005;5:615-25.
7. Zendman AJ, Ruiter DJ, Van Muijen GN. Cancer/testis-associated genes: Identification, expression profile, and putative function. J Cell Physiol 2003;194:272-88.
8. Garg M, Chaurasiya D, Rana R, et al. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer. Clin Cancer Res 2007;13:1421-8.
9. Shankar S, Mohapatra B, Suri A. Cloning of a novel human testis mRNA specifically expressed in testicular haploid germ cells, having unique palindromic sequences and encoding a leucine zipper dimerization motif. Biochem Biophys Res Commun 1998;243:561-5.
10. Jagadish N, Rana R, Selvi R, et al. Characterization of a novel human sperm-associated antigen 9 (SPAG9) having structural homology with c-Jun N-terminal kinase-interacting protein. Biochem J 2005;389:73-82.
11. Qi M, Elion EA. MAP kinase pathways. J Cell Sci 2005;118:3569-72.
12. Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP. Scaffold proteins of MAP-kinase modules. Oncogene 2007;26:3185-202.
13. Lee CL, Onesime D, Reddy CD, Dhanasekaran N, Reddy EP. JLP: A scaffolding protein that tethers JNK/p38 MAPK signaling modules and transcription factors. Proc Natl Acad Sci U S A 2002;99:14189-94.
14. Kelkar N, Standen CL, Davis RJ. Role of the JIP4 scaffold protein in the regulation of mitogen-activated protein kinase signaling pathways. Mol Cell Biol 2005;25:2733-43.
15. Kashef K, Xu H, Reddy P, Dhanasekaran DN. Endodermal differentiation of murine embryonic carcinoma cells by retinoic acid requires JLP, a JNK-scaffolding protein. J Cell Biochem 2006;98:715-22.
16. Willis S, Hutchins AM, Hammet F, et al. Detailed gene copy number and RNA expression analysis of the 17q12-23 region in primary breast cancers. Genes Chromosomes Cancer 2003;36:382-92.
17. Kitahara O, Katagiri T, Tsunoda T, Harima Y, Nakamura Y. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia 2002;4:295-303.
18. Linn SC, West RB, Pollack JR, et al. Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans. Am J Pathol 2003;163:2383-95.
19. Helm J, Enkemann SA, Coppola D, Barthel JS, Kelley ST, Yeatman TJ. Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma. Clin Cancer Res 2005;11:2478-85.
20. Rana R, Jagadish N, Garg M, et al. Small interference RNA-mediated knockdown of sperm associated antigen 9 having structural homology with c-Jun N-terminal kinase-interacting protein. Biochem Biophys Res Commun 2006;340:158-64.
21. Higgins JP, Shinghal R, H Gill, et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol 2003;162:925-32.
22. Lam JS, Pantuck AJ, Belldegrun AS, Figlin RA. Protein expression profiles in renal cell carcinoma: staging, prognosis, and patient selection for clinical trials. Clin Cancer Res 2007;13:703-8s.
23. Price JT, Bonovich MT, Kohn EC. The biochemistry of cancer dissemination. Crit Rev Biochem Mol Biol 1997;32:175-253.
24. Neumann E, Engelsberg A, Decker J, et al. Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and Glycoprotein 75 in human RCC: candidates for T-Cell-based immunotherapies. Cancer Res 1998;58:4090-5.
25. Yamanaka K, Miyake H, Hara I, et al. Expression of MAGE genes in renal cell carcinoma. Int J Mol Med 1998;2:57-60.
26. Rana R, Jagadish N, Garg M, et al. Immunogenicity study of recombinant human sperm associated antigen 9 (SPAG9) in bonnet macaque (Macaca radiata). Hum Reprod 2006;21:2894-900.
27. Jagadish N, Rana R, Mishra D, Garg M, Selvi R, Suri A. Characterization of immune response in mice to plasmid DNA encoding human sperm associated antigen 9 (SPAG9). Vaccine 2006;24:3695-703.
28. Tureci O, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M. Identification of meiosis-specific protein as a member of the class of cancer/ testis antigens. Proc Natl Acad Sci U S A 1998;95:5211-6.
29. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000;103:239-52.
30. Haefliger JA, Tawadros T, Meylan L, et al. The scaffold protein IB1/JIP-1 is a critical mediator of cytokine-induced apoptosis in pancreatic β cells. J Cell Sci 2003;116:1463-9.
31. Willoughby EA, Collins MK. Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein β-arrestin 2. J Biol Chem 2005;280:25651-8.
32. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000;16:168-74.
33. Wischnewski F, Pantel K, Schwarzenbach H. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. Mol Cancer Res 2006;4:339-49.
34. Soussi T, Dehouche K, Beroud C. p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis. Hum Mutat 2000;15:105-13.
35. Gurova KV, Hill JE, Razorenova OV, Chumakov PM, Gudkov AV. p53 pathway in renal cell carcinoma is repressed by a dominant mechanism. Cancer Res 2004;64:1951-8.
36. Zigeuner R, Ratschek M, Rehak P, Schips L, Langner C. Value of p53 as a prognostic marker in histologic subtypes of RCC: a systemic analysis of primary and metastatic tumor tissue. Urology 2004;63:651-5.
37. Wei CL, Wu Q, Vega SV, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 2006;124:207-19.